Literature DB >> 11474162

Can pre-treatment with beta-agonists reduce stress test time and the use of atropine in dobutamine stress testing?

M Y Desai1, E De la Peña-Almaguer, F Mannting.   

Abstract

AIM: To determine whether the use of inhaled beta-agonists decreases the duration of dobutamine stress testing (DAS), reduces the amount of dobutamine infused and decreases the use of atropine.
METHODS: 34 patients on beta-agonists (group A) (mean age 65 +/- 8 years) and 32 patients not on beta-agonists or beta-blockers (group B) (mean age 65 +/- 10 years) undergoing DAS with SPECT were enrolled.
RESULTS: The time of infusion of dobutamine in group A was 6.41 +/- 1.58 min and in group B was 9.77 +/- 3.60 min (p < 0.001). The amount of dobutamine infused was 10.64 +/- 5 mg in group A and 19.20 +/- 8 mg in group B (p < 0.001). In group A, 2 of 34 patients and 18 of 32 patients in group B needed atropine to reach peak HR (p < 0.001).
CONCLUSION: Patients on short acting beta-agonists require smaller amounts of dobutamine with a shorter infusion time during DAS, and lesser use of side-effect prone atropine. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474162     DOI: 10.1159/000047363

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosis of myocardial ischemia.

Authors:  Sanjay K Prasad; Dudley J Pennell
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Dobutamine stress test and beta-agonist - a potential concern for nuclear cardiology testing: a case report.

Authors:  Cevher Ozcan; Barry L Zaret
Journal:  Cases J       Date:  2009-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.